- Generic name
- Palonosetron
- Strength
- .075 mg/1.5 ml
- Dosage form
- Injection
- Manufactured by
- The ACME Laboratories Ltd.
Patron 1.5 Injection
About Patron 1.5 .075 mg/1.5 ml Injection
Patron 1.5.075 mg/1.5 ml is a injection product of The ACME Laboratories Ltd. that contains Palonosetron. It is an anti-emetic medicine, meaning it acts against nausea and vomiting.
There are 16 brands of Palonosetron listed in Bangladesh.
What is Patron 1.5 .075 mg/1.5 ml Injection?
Patron 1.5.075 mg/1.5 ml injection is a medicine made by The ACME Laboratories Ltd. The injection is given by a doctor or nurse, usually as a single dose before treatment. Patron 1.5 is an injection that contains Palonosetron, a medicine from the anti-emetic group. The doctor will decide the exact dose and course for each patient.
Uses of Patron 1.5
It is an anti-emetic medicine, meaning it acts against nausea and vomiting. It is also used for uncontrolled nausea and vomiting and for nausea and vomiting caused by chemotherapy or radiotherapy. It helps with acute and delayed nausea and vomiting caused by chemotherapy, including on the day of treatment and on later days. Your doctor will decide if it is right for your situation.
How to use Patron 1.5
Patron 1.5 is given as an injection by a doctor or nurse, usually into a vein. Patron 1.5 is given as an injection by a healthcare professional. Do not inject it yourself unless a doctor has shown you how. Do not attempt to inject it yourself. Ask your doctor or pharmacist about anything you are unsure of, including how the injection will be given and what to expect afterwards. If you miss a dose, ask your doctor or pharmacist what to do.
Side effects of Patron 1.5
Not everyone who takes it will have these effects. Do not self-treat side effects without advice. Do not try to treat side effects yourself without asking a healthcare professional first. Tell your doctor if these bother you or do not settle. Ask your doctor or pharmacist about anything unusual you notice after taking Patron 1.5, and seek medical help promptly if you have a severe reaction or any symptom that worries you.
Safety and precautions
Do not receive Patron 1.5 if you are allergic to Palonosetron or any ingredient in the injection. Before treatment, tell your doctor about all your medical conditions and medicines. Patron 1.5 should not be given to anyone known to be allergic to Palonosetron or to any of the ingredients in the injection. Keep out of reach of children.
Frequently asked questions
What does Patron 1.5 treat?
It is an anti-emetic medicine, meaning it acts against nausea and vomiting. It is also used for uncontrolled nausea and vomiting and for nausea and vomiting caused by chemotherapy or radiotherapy.
How is Patron 1.5 used?
Patron 1.5 is given as an injection by a doctor or nurse, usually into a vein. Patron 1.5 is given as an injection by a healthcare professional.
Can Patron 1.5 cause side effects?
Not everyone who takes it will have these effects. Do not self-treat side effects without advice.
Who should be careful with Patron 1.5?
Do not receive Patron 1.5 if you are allergic to Palonosetron or any ingredient in the injection. Before treatment, tell your doctor about all your medical conditions and medicines.
Indications
- Acute and delayed nausea and vomiting
- Uncontrolled nausea and vomiting
- Chemotherapy-induced nausea and vomiting (CINV): Acute CINV resulting in on the day of treatment with certain types of chemotherapy
- Delayed CINV resulting in on days later with certain types of chemotherapy ... Read more
- Acute and delayed nausea and vomiting
- Uncontrolled nausea and vomiting
- Chemotherapy-induced nausea and vomiting (CINV): Acute CINV resulting in on the day of treatment with certain types of chemotherapy
- Delayed CINV resulting in on days later with certain types of chemotherapy
- Radiotherapy-induced nausea and vomiting (RINV)
- Post-operative & Post-discharge nausea and vomiting (PONV & PDNV).
Pharmacology
Pharmacokinetics: Palonosetron exhibits linear dose-proportional pharmacokinetics over the doserange 1-90 pg/kg in healthy subjects and in patients with cancer. In cancer patients receiving single intravenous doses of Palonosetron in this dose range, the mean maximum plasma concentration (Cmax) ranges from 0.89 to 336 ng/ml and the area under the plasma concentration-time curve from zero to infinity (AUCo-co) ranges from 13.8 to 957 ng.h/ml. Palonosetron has a volume of distribution of approximately 6.9-7.9 L/kg, with approximately 62% bound to plasma proteins. Approximately 50% of Palonosetron is metabolized into two inactive metabolites that exhibit <1% of the 5-HT3 receptor antagonist activity. Approximately 40% of the drug is metabolised via kidney, 50% by liver CYP2D6 (mainly), CYP3A4 and CYP1A2 isoenzymes. About 50% of the drug goes under metabolism. After a single intravenous dose, approximately 40% is excreted as unchanged drug in the urine after 144 hours. Total body clearance of Palonosetron is 160±35 ml/h/kg, and renal clearance is 66.5±18.2 ml/h/kg in healthy subjects. Palonosetron exhibits a longer half-life (40 hours) and has a greater 5-HT3 receptor binding affinity.
Dosage & Administration
Chemotherapy-induced nausea and vomiting: Adult tablet dosage: 0.5 mg administered approximately 1 hour prior to the start of chemotherapy. Adult IV dosage: A single IV dose of 0.25 mg should be administered over 30 seconds approximately 30 minutes before the start of chemotherapy.
Radiotherapy-induced nausea and vomiting: A single IV dose of 0.25 mg should be administered over 30 seconds approximately 30 minutes before each week of radiation fraction.
Post-operative nausea and vomiting: A single IV dose of 0.075 mg should be administered over 10 seconds immediately before induction of anesthesia.
Children dosage: (1 month to 17 years): A single IV dose at 20 mcg/kg body weight. Which maximum dose is 1.5 mg.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Overdose Effects
Storage Conditions
Alternative brands of Palonosetron
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.